0001209191-24-000019.txt : 20240102
0001209191-24-000019.hdr.sgml : 20240102
20240102110921
ACCESSION NUMBER: 0001209191-24-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Decker Lisa Lynn
CENTRAL INDEX KEY: 0001783056
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 24500934
MAIL ADDRESS:
STREET 1: C/O ATRECA INC.
STREET 2: 500 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-28
0
0001117480
CHIMERIX INC
CMRX
0001783056
Decker Lisa Lynn
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
1
0
0
0
0
Stock Option (Right to Buy)
0.92
2023-12-28
4
A
0
100000
0.00
A
2033-12-27
Common Stock
100000
100000
D
One-third of the shares subject to the stock option will vest and become exercisable on December 28, 2024 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option is fully vested on December 28, 2026, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).
/s/ Michael Alrutz, Attorney-In-Fact
2023-12-30